Aurubis AG Earnings Call Transcripts
Fiscal Year 2026
-
Operating EBT rose 15% sequentially in Q2, with H1 results broadly matching last year. Guidance for full-year Operating EBT and EBITDA was raised, supported by high metal prices, strong copper demand, and strategic project progress.
-
Q1 2025-2026 saw strong revenue growth and higher metal prices, but cash flow and ROCE declined due to increased working capital and investments. Full-year guidance for operating EBT and EBITDA was raised, with strategic projects on track and robust demand for copper products.
Fiscal Year 2025
-
Solid financial performance with strong cash flow and resilience despite lower TC/RCs and one-off items. Strategic projects advanced, dividend increased, and guidance for 2025/2026 maintained amid tight raw material markets and supportive metal prices.
-
Aurubis is executing a focused strategy to maximize returns from recent investments, drive free cash flow, and expand its multi-metal portfolio, emphasizing sustainability and operational excellence. The company targets strong EBITDA growth, 15% ROCE by 2028-2029, higher shareholder returns, and leadership in Europe and North America.
-
Operating EBT and EBITDA remained robust despite major maintenance, with strong cash flow and improved guidance for the year. Strategic investments, especially in the U.S., are progressing, and market conditions support stable demand and high revenues from key products.
-
Operating EBT and EBITDA for the first half of FY 2024-2025 remained robust, supported by higher metal prices, strong sulfuric acid revenues, and effective cost management. Strategic investments are progressing, with guidance for the full year confirmed near the midpoint of the forecast range.
-
Operating EBT rose 17.5% to €130 million in Q1, with strong cash flow and robust segment performance. Strategic investments and plant security initiatives advanced, while guidance for the year remains unchanged. Sulfuric acid sales and copper prices are key earnings drivers.
Fiscal Year 2024
-
Robust FY 2023-2024 results with operating EBT up 19% to €413 million and net cash flow of €537 million, despite major investments and ramp-up costs. Strategic projects are progressing, with €50 million ramp-up costs expected in FY 2024-2025 and a dividend increase proposed.
-
Nine-month operating EBT rose 30% year-over-year to EUR 333 million, driven by strong metal results, higher treatment charges, and lower energy costs, despite a major maintenance shutdown. Full-year guidance is confirmed at the upper end, with strategic investments progressing on schedule.